T1 Intervention 1498 1506 pancreas
T2 Biomarker 356 360 PCCs
T3 Protein 1007 1016 molecular
T4 Biomarker 588 610 PDAC tumorigenesis8-10
T5 Level 1119 1146 PSCs acting on cancer cells
T6 Biomarker 174 177 PSC
T7 Level 210 222 dense stroma
T8 Condition 1220 1226 tumour
T9 Biomarker 1303 1307 PDAC
T10 Gene 1184 1205 genetic Lifr deletion
T11 Biomarker 34 38 PDAC
T12 Biomarker 805 809 PCCs
T13 Level 342 348 cancer
T14 Biomarker 626 630 PSCs
T15 Biomarker 588 592 PDAC
T16 Protein 1487 1490 LIF
T17 Protein 1073 1076 LIF
T18 Biomarker 548 551 PSC
T19 Condition 1945 1951 tumour
T20 Biomarker 1737 1741 PDAC
T21 Level 1343 1349 cancer
T22 Level 1134 1140 cancer
T23 Biomarker 1568 1572 PDAC
T25 Species 1308 1313 mouse
T26 Protein 1628 1631 LIF
T27 Level 1452 1462 human PDAC
T28 Protein 1167 1170 LIF
T29 Biomarker 1119 1122 PSC
T30 Level 1343 1354 cancer cell
T31 Biomarker 1119 1123 PSCs
T32 Species 1435 1440 mouse
T33 Condition 1044 1071 leukaemia inhibitory factor
T34 Condition 380 386 tumour
T35 Condition 670 676 tumour
T36 Biomarker 174 178 PSCs
T37 Condition 277 287 biology1,2
T38 Biomarker 322 326 PSCs
T39 Level 147 172 pancreatic stellate cells
T40 Level 342 353 cancer cell
T41 Biomarker 796 800 PSCs
T42 Biomarker 626 629 PSC
T43 Biomarker 877 881 PDAC
T44 Protein 1730 1733 LIF
T45 Level 2002 2008 cancer
T46 Biomarker 322 325 PSC
T47 Level 322 354 PSCs and pancreatic cancer cells
T48 Biomarker 796 799 PSC
T49 Condition 1652 1658 tumour
T50 Level 1134 1145 cancer cell
R1 Relation Arg1:T6 Arg2:T36
